IRP
EW icon

Investment Research Partners’s Edwards Lifesciences EW Stock Holding History

Investment Research Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$604K Buy
6,678
+435
+7% +$36.4K 0.2% 115
2026
Q1 		$500K Buy
6,243
+259
+4% +$21.4K 0.2% 115
2025
Q4 		$510K Buy
5,984
+9
+0.2% +$739 0.22% 107
2025
Q3 		$494K Buy
+5,975
New +$467K 0.22% 110

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Investment Research Partners's EW Position: Q2 2026 in Review

Investment Research Partners increased its Edwards Lifesciences (EW) stake by 7% in Q2 2026, buying an estimated $36.4K and bringing the position to 6,678 shares worth $604K. The position accounts for 0.2% of the portfolio, ranked #115.

Investment Research Partners first reported a position in EW in Q3 2025 and has held it in 4 quarters since. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Investment Research Partners held 6,678 shares of Edwards Lifesciences worth $604K as of Q2 2026.
  • Investment Research Partners bought 435 Edwards Lifesciences shares in Q2 2026, an estimated $36.4K.
  • Edwards Lifesciences made up 0.2% of Investment Research Partners's portfolio in Q2 2026, its #115 holding.
  • Investment Research Partners first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • 973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Investment Research Partners's 13F filing for Q2 2026, filed 4 Aug 2026.